Literature DB >> 6128450

Leukotriene B4, an inflammatory mediator in gout.

S A Rae, E M Davidson, M J Smith.   

Abstract

Leukotriene B4 (LTB4), a metabolite of arachidonic acid and a potent cytotaxin, is generated by human peripheral polymorphonuclear leucocytes (PMNs) exposed to monosodium urate crystals (MSU). The leukotriene is present in gouty effusions in concentrations significantly greater than those found in synovial fluid from patients with active rheumatoid arthritis or osteoarthritis. Further metabolism and biological deactivation of LTB4 by PMNs are partly inhibited by MSU. It is concluded that LTB4 is an important chemical mediator in an acute gouty attack.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6128450     DOI: 10.1016/s0140-6736(82)92785-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

3.  Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.

Authors:  D M Aked; S J Foster
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

4.  Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

5.  Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.

Authors:  D E Griswold; S Hoffstein; P J Marshall; E F Webb; L Hillegass; P E Bender; N Hanna
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

Review 6.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

7.  Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential.

Authors:  M Fisher; K S Upchurch; P H Levine; M H Johnson; C H Vaudreuil; A Natale; J J Hoogasian
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

8.  Inhibition of tissue damage by the arachidonate lipoxygenase inhibitor BW755C.

Authors:  G A Higgs; K G Mugridge; S Moncada; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 9.  Mechanisms of inflammation in gout.

Authors:  Nathalie Busso; Alexander So
Journal:  Arthritis Res Ther       Date:  2010-04-26       Impact factor: 5.156

10.  Lipoxygenase products in inflammatory synovial fluids and other exudates.

Authors:  P B Costello; A N Baer; F A Green
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.